
Sign up to save your podcasts
Or


The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.3
15931,593 ratings
The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why DeepSeek is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the bioscience industry. Shara Tibken hosts.
Sign up for the WSJ's free Technology newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,835 Listeners

1,720 Listeners

970 Listeners

4,345 Listeners

404 Listeners

420 Listeners

675 Listeners

1,425 Listeners

1,038 Listeners

1,302 Listeners

6,089 Listeners

1,561 Listeners

1,322 Listeners

586 Listeners

151 Listeners

63 Listeners

80 Listeners

142 Listeners